EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
10/09/2025
Back to search
Official data from USPTO
GAMIDA CELL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
GAMIDA CELL
ST13
US500000088606995Class
5, 42
Filing
88606995
Registration
7108147
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
59
Latest update
10/15/2025
Classification
Registered
Trademark type
Word
Nice classes
5, 42
Filing date
09/06/2019
Registration date
07/11/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/11/2023
Last transaction
10/15/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/19/2022
First use in commerce
04/19/2022
Drawing code
4
Owner type
03
Owner location
NAPLES, FL
Examiner
PARK,JENNY K
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
GAMIDA CELL INC.
GAMIDA CELL LTD.
GAMIDA CELL INC.
Representatives
Mark A. Jansen Fenwick & West LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Cell therapy pharmaceutical preparations; pharmaceutical preparations in the field of hematologyoncologyleukemiablood and bone marrow diseases and disorders
Class 42
Research and development in the fields of pharmaceuticalscell therapieshematologyleukemiaoncologyblood and bone marrow diseases and disorders; providing medical and scientific research information in the fields of pharmaceuticalscell therapieshematologyleukemiaoncologyblood and bone marrow diseases and disorders
Publications
History of USPTO decisions and trademark events.
59 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/09/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/09/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/09/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/09/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/09/2025
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
09/10/2025
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
09/10/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/21/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/27/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/11/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
07/11/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/08/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/07/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/02/2023
IUAF
USE AMENDMENT FILED
04/28/2023
EISU
TEAS STATEMENT OF USE RECEIVED
04/28/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/01/2022
EX5G
SOU EXTENSION 5 GRANTED
10/31/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/31/2022
EXT5
SOU EXTENSION 5 FILED
10/20/2022
EEXT
SOU TEAS EXTENSION RECEIVED
10/20/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/22/2022
EX4G
SOU EXTENSION 4 GRANTED
04/20/2022
EXT4
SOU EXTENSION 4 FILED
04/20/2022
EEXT
SOU TEAS EXTENSION RECEIVED
04/20/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/15/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/15/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
02/15/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/15/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/15/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/15/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/30/2021
EX3G
SOU EXTENSION 3 GRANTED
10/28/2021
EXT3
SOU EXTENSION 3 FILED
10/28/2021
EEXT
SOU TEAS EXTENSION RECEIVED
10/28/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/10/2021
EX2G
SOU EXTENSION 2 GRANTED
04/08/2021
EXT2
SOU EXTENSION 2 FILED
04/08/2021
EEXT
SOU TEAS EXTENSION RECEIVED
04/08/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/03/2020
EX1G
SOU EXTENSION 1 GRANTED
10/01/2020
EXT1
SOU EXTENSION 1 FILED
10/01/2020
EEXT
SOU TEAS EXTENSION RECEIVED
10/01/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/28/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/03/2020
PUBO
PUBLISHED FOR OPPOSITION
03/03/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/12/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/29/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/29/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/29/2020
ALIE
ASSIGNED TO LIE
01/28/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/21/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/16/2019
GNRT
NON-FINAL ACTION E-MAILED
12/16/2019
CNRT
NON-FINAL ACTION WRITTEN
12/16/2019
DOCK
ASSIGNED TO EXAMINER
12/09/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/17/2019
NWAP
NEW APPLICATION ENTERED
09/10/2019
Continuous trademark protection
Get notified about every new filing that threatens GAMIDA CELL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.